BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23461901)

  • 1. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.
    Selvakumaran M; Amaravadi RK; Vasilevskaya IA; O'Dwyer PJ
    Clin Cancer Res; 2013 Jun; 19(11):2995-3007. PubMed ID: 23461901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
    Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
    Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
    Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
    Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of signaling through SEK1 and MKK7 yields differential responses in hypoxic colon cancer cells treated with oxaliplatin.
    Vasilevskaya IA; Selvakumaran M; O'Dwyer PJ
    Mol Pharmacol; 2008 Jul; 74(1):246-54. PubMed ID: 18436711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.
    Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H
    Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma.
    Guo XL; Li D; Sun K; Wang J; Liu Y; Song JR; Zhao QD; Zhang SS; Deng WJ; Zhao X; Wu MC; Wei LX
    J Mol Med (Berl); 2013 Apr; 91(4):473-83. PubMed ID: 23052483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly-S-nitrosated human albumin enhances the antitumor and antimetastasis effect of bevacizumab, partly by inhibiting autophagy through the generation of nitric oxide.
    Ishima Y; Inoue A; Fang J; Kinoshita R; Ikeda M; Watanabe H; Maeda H; Otagiri M; Maruyama T
    Cancer Sci; 2015 Feb; 106(2):194-200. PubMed ID: 25457681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
    Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis.
    Selvakumaran M; Yao KS; Feldman MD; O'Dwyer PJ
    Biochem Pharmacol; 2008 Feb; 75(3):627-38. PubMed ID: 18178171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.
    Hu YL; DeLay M; Jahangiri A; Molinaro AM; Rose SD; Carbonell WS; Aghi MK
    Cancer Res; 2012 Apr; 72(7):1773-83. PubMed ID: 22447568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.
    Abdul Rahim SA; Dirkse A; Oudin A; Schuster A; Bohler J; Barthelemy V; Muller A; Vallar L; Janji B; Golebiewska A; Niclou SP
    Br J Cancer; 2017 Sep; 117(6):813-825. PubMed ID: 28797031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice.
    Kurdi A; Cleenewerck M; Vangestel C; Lyssens S; Declercq W; Timmermans JP; Stroobants S; Augustyns K; De Meyer GRY; Van Der Veken P; Martinet W
    Biochem Pharmacol; 2017 Aug; 138():150-162. PubMed ID: 28642033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation.
    Xie CM; Chan WY; Yu S; Zhao J; Cheng CH
    Free Radic Biol Med; 2011 Oct; 51(7):1365-75. PubMed ID: 21763418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
    Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
    Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
    Mei L; Chen Y; Wang Z; Wang J; Wan J; Yu C; Liu X; Li W
    Br J Pharmacol; 2015 May; 172(9):2232-45. PubMed ID: 25521075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.
    Zinn RL; Gardner EE; Dobromilskaya I; Murphy S; Marchionni L; Hann CL; Rudin CM
    Mol Cancer; 2013 Mar; 12():16. PubMed ID: 23452820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-securinine induced the human colon cancer SW480 cell autophagy and its molecular mechanism.
    Xia YH; Cheng CR; Yao SY; Zhang Q; Wang Y; Ji ZN
    Fitoterapia; 2011 Dec; 82(8):1258-64. PubMed ID: 21907765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death.
    Kim SY; Song X; Zhang L; Bartlett DL; Lee YJ
    Biochem Pharmacol; 2014 Mar; 88(2):178-88. PubMed ID: 24486574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
    Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z
    Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.